North America Drug Discovery Informatics Market Size & Outlook

The drug discovery informatics market in North America is expected to reach a projected revenue of US$ 2,827.9 million by 2030. A compound annual growth rate of 11.3% is expected of North America drug discovery informatics market from 2025 to 2030.
Revenue, 2024 (US$M)
$1,491.9
Forecast, 2030 (US$M)
$2,827.9
CAGR, 2025 - 2030
11.3%
Report Coverage
North America

North America drug discovery informatics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

North America drug discovery informatics market, 2018-2030 (US$M)

North America drug discovery informatics market highlights

  • The North America drug discovery informatics market generated a revenue of USD 1,491.9 million in 2024.
  • The market is expected to grow at a CAGR of 11.3% from 2025 to 2030.
  • In terms of segment, sequence analysis platforms was the largest revenue generating service in 2024.
  • Sequence Analysis Platforms is the most lucrative service segment registering the fastest growth during the forecast period.
  • Country-wise, U.S. is expected to register the highest CAGR from 2025 to 2030.

North America data book summary

Market revenue in 2024USD 1,491.9 million
Market revenue in 2030USD 2,827.9 million
Growth rate11.3% (CAGR from 2025 to 2030)
Largest segmentSequence analysis platforms
Fastest growing segmentSequence Analysis Platforms
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSequence Analysis Platforms, Molecular Modelling, Docking, Clinical Trial Data Management
Key market players worldwideCertara Inc Ordinary Shares, Boehringer Ingelheim, Infosys Ltd ADR, Charles River Laboratories International Inc, Eli Lilly and Co, Novo Nordisk A/S ADR, Oracle Corp, Accenture PLC Class A, Agilent Technologies Inc, Illumina Inc, Eurofins Scientific SE, Jubilant Biosys, Selvita, ChemAxon, Albany Molecular Research

Other key industry trends

  • In terms of revenue, North America region accounted for 40.9% of the global drug discovery informatics market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,748.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Drug Discovery Informatics Market Companies

Name Profile # Employees HQ Website

North America drug discovery informatics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug discovery informatics market will help companies and investors design strategic landscapes.


Sequence analysis platforms was the largest segment with a revenue share of 40.69% in 2024. Horizon Databook has segmented the North America drug discovery informatics market based on sequence analysis platforms, molecular modelling, docking, clinical trial data management covering the revenue growth of each sub-segment from 2018 to 2030.


North America market encompasses of U.S. and Canada. Higher incidence rates of different infectious diseases and oncology diseases are expected to drive demand for informatics solutions to aid drug discovery and development. 

Well defined regulatory framework for is responsible for higher penetration of market players which subsequently leads to generation of industrial revenue. The simultaneous developments of next generation sequencing and chemical laboratories in the region are the highest impact rendering factor for the growth of drug discovery informatics. 

As these segments are capital intensive, high R&D investment markets and complement each other to a significant extent, their inter-related development dependencies are integral to their development.

Reasons to subscribe to North America drug discovery informatics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America drug discovery informatics market databook

  • Our clientele includes a mix of drug discovery informatics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America drug discovery informatics market , including forecasts for subscribers. This continent databook contains high-level insights into North America drug discovery informatics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America drug discovery informatics market size, by country, 2018-2030 (US$M)

North America Drug Discovery Informatics Market Outlook Share, 2024 & 2030 (US$M)

North America drug discovery informatics market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more